TIAA Trust, National Association’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,478
Closed -$587K 521
2025
Q4
$587K Buy
3,478
+10
+0.3% +$1.62K ﹤0.01% 462
2025
Q3
$501K Sell
3,468
-18
-0.5% -$2.46K ﹤0.01% 486
2025
Q2
$441K Buy
3,486
+153
+5% +$18.8K ﹤0.01% 478
2025
Q1
$426K Buy
3,333
+179
+6% +$24.3K ﹤0.01% 468
2024
Q4
$417K Buy
3,154
+787
+33% +$111K ﹤0.01% 472
2024
Q3
$345K Buy
2,367
+38
+2% +$5.5K ﹤0.01% 513
2024
Q2
$320K Sell
2,329
-123
-5% -$16.4K ﹤0.01% 503
2024
Q1
$336K Buy
2,452
+14
+0.6% +$1.91K ﹤0.01% 493
2023
Q4
$331K Hold
2,438
﹤0.01% 474
2023
Q3
$298K Buy
+2,438
New +$310K ﹤0.01% 484

Other funds holding IBB

TIAA Trust, National Association's IBB Position: Q1 2026 in Review

TIAA Trust, National Association sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 3,478 shares — an estimated $587K sold.

TIAA Trust, National Association first reported a position in IBB in Q3 2023 and held it in 10 quarters. The position peaked at $587K in Q4 2025. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • TIAA Trust, National Association reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 3,478 iShares Biotechnology ETF shares in Q1 2026, an estimated $587K.
  • TIAA Trust, National Association first reported a position in iShares Biotechnology ETF in Q3 2023 and held it in 10 quarters.
  • TIAA Trust, National Association's iShares Biotechnology ETF position peaked at $587K in Q4 2025.
  • 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on TIAA Trust, National Association's 13F filing for Q1 2026, filed 12 May 2026.